ECL logo

ECOLAB INC

ECLNYSE
πŸ† #199 by market capEarnings Oct 27 Β· PreUS Equity
$278.66β–Ό $1.64 (βˆ’0.59%)
Live
πŸ””
Track ECL
Get earnings, price moves & breaking news on Telegram
Track
24hβ–Ό 0.6%
7dβ–² 0.9%
14dβ–² 1.5%
30dβ–Ό 2.8%
ytdβ–² 6.1%
1yβ–² 2.1%
🏦Market Cap
$78.43B
Mid Cap
πŸ“ˆRevenue Growth (YoY)
+7.1%
Slowing
πŸ“ŠGross Margin
44.2%
Healthy
πŸ’΅FCF Margin
11.1%
Healthy
βš–οΈP/S Ratio
4.7x
Fair
Otter Score
72
Fair

Trading Snapshot

Day Range
$277.31 – $284.04
52-Week Range
$243.15 – $309.27
Volume
$2.44B
Avg Volume
$2.47B
Shares Outstanding
281.4M
Next Earnings
Nov 10, 2026

Fundamentals Snapshot

Annual Revenue
$16.08B
Last Q Revenue
$4.42B
P/E Ratio
37.0
P/S Ratio
4.7x
EPS (TTM)
$7.45
Dividend Yield
1.02%
Dilution (1yr)
βˆ’0.5%

Why Investors Own ECL

  • βœ“High-growth profile β€” revenue up +42.8% YoY with expanding US Equity exposure.
  • βœ“Healthy economics β€” 76% gross margin and 6% free-cash-flow margin.
  • βœ“New products and segments could unlock additional revenue streams.
⚠️ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

ECL logo

ECOLAB INC

ECL
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$16.1Bβ–² +2.2% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
44.5%β–² +2.4% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$2.9Bβ–² +11.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$1.9Bβ–² +4.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
284.2Mβ–Ό βˆ’0.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$8.8Bβ–Ό βˆ’$1.8B YoY
StockOtter Β· stockotter.space

About ECOLAB INC

Ecolab Inc. provides water, hygiene, and infection prevention solutions and services in the United States and internationally. The company operates through four segments: Global Water, Global Institutional & Specialty, Global Pest Elimination, and Global Life Sciences. The Global Water segment offers water treatment and process applications, and cleaning and sanitizing solutions to manufacturing, food and beverage processing, transportation, chemical, primary metals and mining, power generation, global refining, petrochemical, pulp and paper industries. The Global Institutional & Specialty segment provides cleaning and sanitizing products to the foodservice, healthcare, hospitality, lodging, government, education and retail industries. The Global Pest Elimination segment provides pest elimination services to detect, prevent, and eliminate pests comprising rodents and insects in full-service and quick-service restaurants, food and beverage processors, hotels, grocery operations, and other commercial segments, including education, life sciences, and healthcare. The Global Life Sciences segment provides cleaning and contamination control solutions to pharmaceutical and personal care manufacturers. It offers its products under the Ecolab, Kay, Purolite, and Bioquell brand names. The company sells its products through field sales and corporate account personnel, distributors, and dealers. Ecolab Inc. was founded in 1923 and is headquartered in Saint Paul, Minnesota.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
72/100

Analyst Ratings

β“˜
Consensus
Buy
30 analysts
Strong Buy9
Buy15
Hold6
Sell0
Strong Sell0
Ratings as of Sep 2026

Latest News & Updates